MedPath

Efficacy evaluation of Tiotropium Respimat with AeroChamber Plus

Not Applicable
Conditions
COPD
Registration Number
JPRN-UMIN000013980
Lead Sponsor
Hamamatsu medical center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. Known severe allergy to any drugs. 2. Patients with benign prostatic hypertrophy or glaucoma. 3. Patients who cannot parchase AeroChamber Plus. 4. Patients who cannot use tiotropium respimat with inhalation assistance.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of forced expiratory volume in 1 second (FEV1) after inhalation therapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath